Enzymatica’s results published in The Journal of Physiology
Study results show that Enzymatica’s mouth spray, ColdZyme, reduces viral load and inhibits its spread, leading to fewer sick days and milder symptoms. The study findings have now been published in the highly ranked journal The Journal of Physiology.
Enzymatica has developed ColdZyme, a medical device mouth spray used at the first signs of cold and flu-like symptoms. The spray creates a barrier in the throat that captures viruses and inhibits their spread. ColdZyme is certified under the EU Medical Device Regulation (MDR).